Error loading player: No playable sources found

W101e

Panel Questions – Bioassay Capabilities and Applications

Date
May 13, 2020
This product is not available for individual purchase, but it is available as part of the following products:
Thumbnail for CMC Strategy Forum Europe 2020
The purpose of the CMC Strategy Forum Europe 2020 is to offer a blend of topics that characterize the challenges facing the biotechnology industry in the next decade…

Chairs

Speaker Image for Chana Fuchs
CDER, FDA
Speaker Image for Martin Schiestl
Sandoz GmbH

Panelists

Speaker Image for Gaël Debauve
UCB Pharma S.A.
Speaker Image for Johann Holzmann
Novartis Pharma AG
Speaker Image for Mihaela Buda
EDQM-Council of Europe
Speaker Image for Niklas Ekman
Finnish Medicines Agency (FIMEA)
Speaker Image for Steffen Gross
Paul-Ehrlich-Institut

Related Products

Thumbnail for KBI Biopharma Inc. Vendor Showcase
KBI Biopharma Inc. Vendor Showcase
KBI Biopharma is a leading contract development and manufacturing organization for the biopharmaceutical industry. We accelerate and optimize drug development and manufacturing programs for our client partners…
Thumbnail for Bioassays Reflecting Fc Effector Functions - Selecting the Most Relevant Assay Type Considering the Molecules Mode of Action and the Assays Performance Characteristics
Bioassays Reflecting Fc Effector Functions - Selecting the Most Relevant Assay Type Considering the Molecules Mode of Action and the Assays Performance Characteristics
Stimulation of immune-mediated effector functions via the antibody Fc domain such as complement-dependent cytotoxicity (CDC) or antibody-dependent cell-mediated cytotoxicity (ADCC) are key mechanisms of action (MoA) of many therapeutic antibodies…